Project Details
Project Description
Monash Health HREC Ref: 15024A
| Status | Finished |
|---|---|
| Effective start/end date | 12/12/18 → 11/12/23 |
A Phase I/IIa Study of BMS 986148, a Mesothelin Directed Antibody Drug Conjugate, in Subjects with Select Advanced Solid Tumors
- Day, Daphne (Primary Chief Investigator (PCI))
- Markman, Ben (Chief Investigator (CI))
- Body, Amy (Primary Chief Investigator (PCI))
Project: Research